CDC\u2019s Investments to Combat Antibiotic Resistance Threats Nationwide : Montana

$972,503 Funding for AR Activities Fiscal Year 2017Funding to local health departments:$374,126 - RAPID DETECTION & RESPONSE to emerging drug-resistant germs is critical to contain the spread of these infections. With 2016 funding, Montana made outbreaks including drug resistant pathogens explicitly reportable. In response to a MRSA cluster in a hospital unit that cares for newborns, the HAI/AR program coordinated screening of patients and staff to identify hidden reservoirs of disease in the facility and the state public health lab tested for related cases.$474,600 - HAI/AR PREVENTION works best when public health and healthcare facilities partner together to implement targeted, coordinated strategies to stop infections and improve antibiotic use. With 2016 funding, Montana worked with the state hospital association, Quality Improvement Organization/Quality Innovation Network, and academic partners to provide tailored support to a majority of the state\u2019s hospitals about measuring and improving antibiotic prescribing and use.$123,777 - FOOD SAFETY projects protect communities by rapidly identifying drug-resistant foodborne bacteria to stop and solve outbreaks and improve prevention. Montana implemented whole genome sequencing of Listeria, Salmonella, Campylobacter and E. coli isolates submitted to its lab and began uploading sequence data into PulseNet for nationwide monitoring of outbreaks and trends. In Fiscal Year 2018, Montana will begin simultaneously monitoring these isolates for resistance genes. When outbreaks are detected, local CDC-supported epidemiologists investigate the cases to stop spread.Montana-2017-CDC-AR-Investments.pd